Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma
Pal, Sumanta K., McDermott, David F., Atkins, Michael B., Escudier, Bernard, Rini, Brian I., Motzer, Robert J., Fong, Lawrence, Joseph, Richard W., Oudard, Stephane, Ravaud, Alain, Bracarda, Sergio, SJournal:
BJU International
DOI:
10.1111/bju.15058
Date:
April, 2020
File:
PDF, 10.34 MB
2020